Table 1 Demographic and clinical characteristics of recipients and donors
Variables | Total number (n = 251) |
|---|---|
Recipient age (y), median | 28 (2–63) |
Children (≤ 16) | 70 (27.9%) |
Adults (> 16) | 181 (72.1%) |
Male sex, n (%) | 140 (55.8%) |
Underling disease (%) | |
AML | 102 (40.6%) |
ALL | 99 (39.4%) |
AA | 20 (8.0%) |
MDS | 19 (7.6%) |
Others | 11 (4.4%) |
Donor age (y), median | 36 (4–64) |
Male donor sex, n (%) | 190 (75.7%) |
Donor–recipient ABO blood type | |
Match, n (%) | 138 (55.0%) |
Major mismatch, n (%) | 53 (21.1%) |
Minor mismatch, n (%) | 60 (23.9%) |
Mononuclear cells (× 108/kg) | 8.74 (6.16–13.97) |
CD34+ cells (× 106/kg) | 2.76 (0.68–6.03) |
IFD prophylaxis | |
Fluconazole | 9 (3.6%) |
Itraconazole | 181 (72.1%) |
Voriconazole | 53 (21.1%) |
Caspofungin | 8 (3.2%) |